Subject(s)
Information Systems/legislation & jurisprudence , Mental Health , Computer Security/legislation & jurisprudence , Confidentiality/legislation & jurisprudence , Health Insurance Portability and Accountability Act , Health Policy , Humans , Internet , Mobile Applications , United States , United States Federal Trade Commission/organization & administration , United States Food and Drug Administration/organization & administrationSubject(s)
Antitrust Laws , Health Care Sector/legislation & jurisprudence , United States Federal Trade Commission/organization & administration , Economic Competition/legislation & jurisprudence , Health Facility Merger/legislation & jurisprudence , History, 21st Century , Law Enforcement , United StatesSubject(s)
Advertising/legislation & jurisprudence , Pharmaceutical Preparations , United States Federal Trade Commission , United States Food and Drug Administration , Community Participation , Drug Industry/legislation & jurisprudence , Humans , Private Sector , Product Labeling/legislation & jurisprudence , United States , United States Federal Trade Commission/organization & administration , United States Food and Drug Administration/organization & administrationABSTRACT
In this interview with William Sage of Columbia University, Federal Trade Commission (FTC) chair Timothy Muris discusses his commission's role in the health care arena. He details the FTC's antitrust and consumer protection activities in a variety of sectors, including hospitals, physicians, and pharmaceuticals. Muris affirms the commission's belief that markets benefit consumers and that markets need basic rules to operate. The FTC's role is to enforce those rules, based on empirical evidence, in as much of the economy as possible, including health care.
Subject(s)
Antitrust Laws , Consumer Advocacy/legislation & jurisprudence , Health Care Sector/legislation & jurisprudence , United States Federal Trade Commission/organization & administration , Drug Industry/legislation & jurisprudence , Economic Competition/legislation & jurisprudence , Government Regulation , Legislation, Hospital , Legislation, Medical , Medicare/legislation & jurisprudence , United StatesSubject(s)
Antitrust Laws , Managed Care Programs/legislation & jurisprudence , United States Federal Trade Commission/legislation & jurisprudence , Health Facility Merger/legislation & jurisprudence , Health Maintenance Organizations/legislation & jurisprudence , Health Policy , Humans , Provider-Sponsored Organizations/legislation & jurisprudence , United States , United States Federal Trade Commission/organization & administrationABSTRACT
When the federal circuit court decided not to grant an injunction to prevent a merger of one city's two major hospitals, the FTC filed an appeal--and a complaint with an administrative law judge. FTC lawyers say this action is within the realm of their responsibility; one hospital's CEO says that FTC complaint has a taint of vengefulness.
Subject(s)
Health Facility Merger/legislation & jurisprudence , United States Federal Trade Commission/organization & administration , Antitrust Laws , Economic Competition , Health Facility Merger/economics , Hospitals, Urban/legislation & jurisprudence , Hospitals, Urban/organization & administration , Michigan , United StatesABSTRACT
Increases in both the cost of medical care and the numbers of providers have generated strong pressure for competition in the medical profession. The Federal Trade Commission strives to maintain such competition free from public and private restraints in order to maximize consumer welfare. The author describes the advantages of these types of competitive practices and discusses the competitive restraints that most concern the FTC: restrictions on ethical advertising, exclusion of competitors, restraints on dispensing drugs, and restrictions on commercial practice locations.